| For: | Xiao EH, Guo D, Bian DJ. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 2009; 15(36): 4582-4586 [PMID: 19777619 DOI: 10.3748/wjg.15.4582] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i36/4582.htm |
| Number | Citing Articles |
| 1 |
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma. HPB 2020; 22(6) doi: 10.1016/j.hpb.2019.12.013
|
| 2 |
Joseph A Breuer, K Hamzah Ahmed, Fares Al-Khouja, Anvesh R Macherla, Jackline M Muthoka, Nadine Abi-Jaoudeh. Interventional oncology: new techniques and new devices. The British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20211360
|
| 3 |
Lin Mu, Julius Chapiro, Jeremiah Stringam, Jean-François Geschwind. Interventional Oncology in Hepatocellular Carcinoma. The Cancer Journal 2016; 22(6) doi: 10.1097/PPO.0000000000000227
|
| 4 |
Ting Luo, Kunpeng Ma, Yi Zhang, Qingwen Xue, Jie Yu, Xing-Jie Liang, Ping Liang. Nanostrategies synergize with locoregional interventional therapies for boosting antitumor immunity. Bioactive Materials 2025; 51 doi: 10.1016/j.bioactmat.2025.05.016
|
| 5 |
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformations. European Journal of Pharmaceutics and Biopharmaceutics 2015; 96 doi: 10.1016/j.ejpb.2015.09.006
|
| 6 |
Marcelo Guimaraes, Renan Uflacker. Locoregional Therapy for Hepatocellular Carcinoma. Clinics in Liver Disease 2011; 15(2) doi: 10.1016/j.cld.2011.03.013
|
| 7 |
Jianzhen Lin, Liangcai Wu, Xue Bai, Yuan Xie, Anqiang Wang, Haohai Zhang, Xiaobo Yang, Xueshuai Wan, Xin Lu, Xinting Sang, Haitao Zhao. Combination treatment including targeted therapy for advanced hepatocellular carcinoma. Oncotarget 2016; 7(43) doi: 10.18632/oncotarget.11954
|
| 8 |
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma. Radiology 2017; 285(1) doi: 10.1148/radiol.2017162555
|
| 9 |
Kenneth N. Huynh, Sriram Rao, Bradley Roth, Theodore Bryan, Dayantha M. Fernando, Farshid Dayyani, David Imagawa, Nadine Abi-Jaoudeh. Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular Carcinoma. Cancers 2023; 15(10) doi: 10.3390/cancers15102738
|
| 10 |
Huan Tong, Xiao Li, Chun Le Zhang, Jin Hang Gao, Shi Lei Wen, Zhi Yin Huang, Fu Qiang Wen, Ping Fu, Cheng Wei Tang. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allografts. Journal of Digestive Diseases 2013; 14(1) doi: 10.1111/1751-2980.12001
|
| 11 |
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo. Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic Therapies. Medicina 2023; 59(6) doi: 10.3390/medicina59061115
|
| 12 |
Mohamed Bouattour, Hélène Marijon, Chantal Dreyer, Sandrine Faivre, Éric Raymond. Thérapies ciblées dans le carcinome hépatocellulaire. La Presse Médicale 2010; 39(7-8) doi: 10.1016/j.lpm.2009.11.016
|
| 13 |
Riccardo Lencioni, Josep M. Llovet, Guohong Han, Won Young Tak, Jiamei Yang, Alfredo Guglielmi, Seung Woon Paik, Maria Reig, Do Young Kim, Gar-Yang Chau, Angelo Luca, Luis Ruiz del Arbol, Marie-Aude Leberre, Woody Niu, Kate Nicholson, Gerold Meinhardt, Jordi Bruix. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial. Journal of Hepatology 2016; 64(5) doi: 10.1016/j.jhep.2016.01.012
|
| 14 |
Sebastian Buschauer, Andreas Koch, Philipp Wiggermann, Martina M�ller, Claus Hellerbrand. Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in�vitro. Oncology Letters 2018; doi: 10.3892/ol.2018.7887
|
| 15 |
Minoru Matsubara, Hidenori Shiraha, Jyunro Kataoka, Masaya Iwamuro, Shigeru Horiguchi, Shin‐ichi Nishina, Nobuyuki Takaoka, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Kazuhide Yamamoto. Des‐γ‐carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2012; 27(10) doi: 10.1111/j.1440-1746.2012.07173.x
|
| 16 |
Rosina Maria Critelli, Federico Casari, Alberto Borghi, Grazia Serino, Cristian Caporali, Paolo Magistri, Annarita Pecchi, Endrit Shahini, Fabiola Milosa, Lorenza Di Marco, Alessandra Pivetti, Simone Lasagni, Filippo Schepis, Nicola De Maria, Francesco Dituri, María Luz Martínez-Chantar, Fabrizio Di Benedetto, Gianluigi Giannelli, Erica Villa. The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment. Cancers 2024; 16(20) doi: 10.3390/cancers16203549
|
| 17 |
Joško Osredkar, Špela Koršič, Uršula Prosenc Zmrzljak, Hana Trček, Peter Popović. Angiogenetic Factors in Hepatocellular Carcinoma During Transarterial Chemoembolization: A Pilot Study. Cancers 2025; 17(16) doi: 10.3390/cancers17162642
|
| 18 |
Yan Fu, Chu Hui Zeng, Chao An, Yue Liu, Ji Hoon Shin, Xiao Li. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their Roles. Cancers 2023; 15(4) doi: 10.3390/cancers15041324
|
| 19 |
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Critical Reviews in Oncology/Hematology 2011; 80(1) doi: 10.1016/j.critrevonc.2010.10.005
|
| 20 |
Xuesong Liu, Linan Yin, Bowen Liu, Xunbo Hou, Yingchen Li, Ruibao Liu. TACE-HAIC Plus Targeted Therapy and Immunotherapy for HCC with Tumor Thrombus and Arteriovenous Fistula. Journal of Hepatocellular Carcinoma 2025; doi: 10.2147/JHC.S567414
|
| 21 |
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32(S2) doi: 10.1007/BF03265492
|
| 22 |
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model. Cancers 2023; 15(12) doi: 10.3390/cancers15123236
|
| 23 |
Xiang Cheng, Ping Sun, Qing-Gang Hu, Zi-Fang Song, Jun Xiong, Qi-Chang Zheng. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses. Journal of Cancer Research and Clinical Oncology 2014; 140(7) doi: 10.1007/s00432-014-1677-4
|
| 24 |
Qin Shi, Tongqiang Li, Songjiang Huang, Yaowei Bai, Yingliang Wang, Jiacheng Liu, Chen Zhou, Yang Chen, Bin Xiong. Transcatheter Arterial Embolization Containing Donafenib Induces Anti-Angiogenesis and Tumoricidal CD8+ T-Cell Infiltration in Rabbit VX2 Liver Tumor. Cancer Management and Research 2021; doi: 10.2147/CMAR.S328294
|
| 25 |
Alexander Gross, Thomas Albrecht. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and Efficacy. CardioVascular and Interventional Radiology 2020; 43(3) doi: 10.1007/s00270-019-02364-w
|
| 26 |
Mario Petrillo, Francesca Patella, Filippo Pesapane, Matteo B Suter, Anna M Ierardi, Salvatore A Angileri, Chiara Floridi, Massimo de Filippo, Gianpaolo Carrafiello. Hypoxia and Tumor Angiogenesis in the Era of Hepatocellular Carcinoma Transarterial Loco-Regional Treatments. Future Oncology 2018; 14(28) doi: 10.2217/fon-2017-0739
|
| 27 |
Chen Zhou, Qi Yao, Hongsen Zhang, Xiaopeng Guo, Jiacheng Liu, Qin Shi, Songjiang Huang, Bin Xiong. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59746-1
|
| 28 |
Nadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, Dayantha Fernando, Nicholas Fidelman, Hanna Javan, Po-Chin Liang, Jen-I Hwang, David K Imagawa. Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S304275
|
| 29 |
Jiang Li, Fan Yang, Jian Li, Zhi-Yong Huang, Qi Cheng, Er-Lei Zhang. Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion. World Journal of Gastrointestinal Surgery 2023; 15(1): 19-31 doi: 10.4240/wjgs.v15.i1.19
|
| 30 |
Iliana Doycheva, Paul J. Thuluvath. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field. Journal of Clinical and Experimental Hepatology 2019; 9(5) doi: 10.1016/j.jceh.2019.07.012
|
| 31 |
Yanming Zhou, Xiaofeng Zhang, Lupeng Wu, Feng Ye, Xu Su, Lehua Shi, Bin Li. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma. BMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-51
|
| 32 |
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in Japan. Clinical Drug Investigation 2012; 32 doi: 10.2165/1163021-S0-000000000-00000
|
| 33 |
Manon Buijs, Diane K. Reyes, Timothy M. Pawlik, Amanda L. Blackford, Riad Salem, Wells A. Messersmith, Colin D. Weekes, Mary Mulcahy, Ihab R. Kamel, Jean‐Francois H. Geschwind. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. Cancer 2013; 119(5) doi: 10.1002/cncr.27859
|
| 34 |
Chen Zhou, Qin Shi, Jiacheng Liu, Songjiang Huang, Chongtu Yang, Bin Xiong. Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive Nanogel. Journal of Hepatocellular Carcinoma 2020; doi: 10.2147/JHC.S282209
|
| 35 |
Ning He, Wenjing Zhao, Wenlong Tian, Ying Wu, Jian Xu, Yunyan Lu, Xudong Chen, Hui Zhao. A cellular senescence-related signature for predicting prognosis, immunotherapy response, and candidate drugs in patients treated with transarterial chemoembolization (TACE). Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01116-8
|